SM

Stanley Medical Research Institute

North America, Maryland, United States, Chevy Chase

Description

The Stanley Medical Research Institute (SMRI) is a nonprofit organization supporting research on the causes of, and treatments for,

Investor Profile

Stanley Medical Research Institute has made 4 investments, with 0 in the past 12 months and 75% as lead.

Stage Focus

  • Grant (50%)
  • Series A (25%)
  • Series E (25%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Medical
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Stanley Medical Research Institute frequently co-invest with?

Novartis Venture Fund
Europe, Basel-Stadt, Switzerland, Basel
Co-Investments: 1
Washington Research Foundation
North America, Washington, United States, Seattle
Co-Investments: 1
Aravis Ventures
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Trevi Health Ventures
North America, New York, United States, New York
Co-Investments: 1
The Grosvenor Funds
North America, District of Columbia, United States, Washington
Co-Investments: 1
WC
North America, Washington, United States, Seattle
Co-Investments: 1
Southern Cross Venture Partners
Oceania, New South Wales, Australia, North Sydney
Co-Investments: 1
ARCH Venture Partners
North America, Illinois, United States, Chicago
Co-Investments: 1

What are some of recent deals done by Stanley Medical Research Institute?

Omeros

Seattle, Washington, United States

Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
GrantJan 28, 2009
Amount Raised: $3,100,000
Omeros

Seattle, Washington, United States

Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
Series EFeb 12, 2007
Amount Raised: $63,000,000
Omeros

Seattle, Washington, United States

Omeros is a clinical-stage biopharmaceutical company developing products focused on inflammation and central nervous system disorders.

BiotechnologyHealth CarePharmaceutical
GrantJan 11, 2007
Amount Raised: $9,000,000
Argolyn Bioscience

Durham, North Carolina, United States

Argolyn Bioscience is a biotechnology company that develops peptide drug candidates to treat serious diseases and disorders

BiotechnologyHealth CareMedicalPharmaceutical
Series ASep 1, 2003
Amount Raised: $1,000,000